• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NAVIGATION, INC. (LOUISVILLE) ADHESIVE PAD 9732500 HEAD TRACKER 25PK; NEUROLOGICAL STEREOTAXIC INSTRUMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NAVIGATION, INC. (LOUISVILLE) ADHESIVE PAD 9732500 HEAD TRACKER 25PK; NEUROLOGICAL STEREOTAXIC INSTRUMENT Back to Search Results
Catalog Number 9732781
Medical Device Problem Code Use of Device Problem (1670)
Health Effect - Clinical Codes Skin Discoloration (2074); Skin Irritation (2076); Iatrogenic Source (2498)
Date of Event 02/10/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Patient information was not made available from the site.Manufacture date of the device could not be determined with the information provided.Instructions for use which accompany this product state: "warning: do not over tighten the strap.Always look for signs of excessive pressure surrounding the em ent head frame site.Over-tightened straps may cause pressure-related injuries such as bruising, skin marks, or nerve damage." no parts have been replaced or returned.Surgeon has been educated on the risk of using this device for long periods of time when it is put on tightly.
 
Event or Problem Description
A medtronic representative reported that the 9732781 head tracker kit was put on in an otorhinolaryngological surgery for the paranasal sinus.The procedure lasted for about 7 hours.There seemed no issue soon after the surgery, however, on the following day, blisters and redness started appearing on the patient¿s forehead, where the device had been put on.The patient was treated by a dermatologist afterwards and the symptoms are improving.The rep had informed the physician prior to the procedure that skin irritation might occur after a long surgery.The rep saw the physician once again on (b)(6), and confirmed that the physician was aware of the possible side effect of using the device for such an extended amount of time.
 
Additional Manufacturer Narrative
Additional information: further investigation was conducted.In addition to instructions for use which accompany this product already reported on initial mdr, it also states, "always screen the patient for adverse reaction to all patient contacting materials, especially adhesives, prior to the procedure.".
 
Additional Manufacturer Narrative
Additional information: patient id, age and gender provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADHESIVE PAD 9732500 HEAD TRACKER 25PK
Common Device Name
NEUROLOGICAL STEREOTAXIC INSTRUMENT
Manufacturer (Section D)
MEDTRONIC NAVIGATION, INC. (LOUISVILLE)
826 coal creek circle
louisville CO 80027
MDR Report Key6397823
Report Number1723170-2017-01023
Device Sequence Number16373319
Product Code HAW
UDI-Device Identifier00613994155573
UDI-Public00613994155573
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K974187
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Medical Equipment Company Technician/Representative
Type of Report Initial,Followup,Followup
Report Date (Section B) 08/23/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Physician
Device Catalogue Number9732781
Initial Date Received by Manufacturer 02/10/2017
Supplement Date Received by Manufacturer06/21/2017
07/26/2017
Initial Report FDA Received Date03/11/2017
Supplement Report FDA Received Date07/19/2017
08/23/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
(B)(4).
Outcome Attributed to Adverse Event Required Intervention;
Patient Age58 YR
-
-